Shuttle Pharmaceuticals (SHPH) News Today $0.79 +0.02 (+2.98%) (As of 09:33 AM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Shuttle Pharmaceuticals enters into sponsored research agreement with UCSFDecember 21, 2024 | markets.businessinsider.comShuttle Pharmaceuticals Holdings, Inc. Engages in Sponsored Research Agreement with UCSFDecember 21, 2024 | americanbankingnews.comShuttle Pharma Enters into Sponsored Research Agreement with the University of California, San Francisco to Advance PSMA Development ProgramDecember 19, 2024 | markets.businessinsider.comShuttle Pharmaceuticals (NASDAQ:SHPH) Trading Down 0.7% - Time to Sell?December 19, 2024 | americanbankingnews.comShuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First PatientNovember 26, 2024 | globenewswire.comShuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharma Provides Third Quarter 2024 Corporate UpdateNovember 15, 2024 | finanznachrichten.deShuttle Pharmaceuticals Holdings, Inc. Advances Phase 2 Clinical Trial for Ropidoxuridine in Glioblastoma TreatmentNovember 13, 2024 | quiverquant.comShuttle Pharma Provides Third Quarter 2024 Corporate UpdateNovember 13, 2024 | globenewswire.comShuttle Pharma (SHPH) Stock Surges on Clinical Trial, Financing and Debt Elimination NewsNovember 2, 2024 | msn.comMicro Cap Company Is Soaring On Phase 2 Trial UpdateOctober 31, 2024 | theglobeandmail.com“Stocks Key Trendlines: PRSO, PFIE, SHPH, BKYI, LIXT on the Verge of Breakthroughs”October 30, 2024 | theglobeandmail.comShuttle Pharmaceuticals doses first patients in Phase 2 trial of RopidoxuridineOctober 30, 2024 | markets.businessinsider.comShuttle Pharmaceuticals (NASDAQ:SHPH) Stock, Short Interest ReportOctober 30, 2024 | benzinga.comShuttle Pharma Pays Off Senior Secured Convertible NoteOctober 30, 2024 | finance.yahoo.comShuttle Pharma Doses First Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with GlioblastomaOctober 30, 2024 | finance.yahoo.comShuttle Pharmaceuticals (NASDAQ:SHPH) Stock Quotes, Forecast and News SummaryOctober 30, 2024 | benzinga.comShuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq RulesOctober 29, 2024 | globenewswire.comShuttle Pharmaceuticals Shares Rise 63% on Drug-Study Site UpdateOctober 29, 2024 | marketwatch.comShuttle Pharma Updates On Clinical Trial Site; Stock SurgesOctober 29, 2024 | markets.businessinsider.comShuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with GlioblastomaOctober 28, 2024 | globenewswire.comShuttle Pharma advances glioblastoma treatment trialSeptember 19, 2024 | uk.investing.comShuttle Pharma Expands Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with GlioblastomaSeptember 16, 2024 | globenewswire.comShuttle Pharmaceuticals Files Delayed Financial Statements, Reports Progress on Drug StudySeptember 5, 2024 | marketwatch.comWhy Shuttle Pharmaceuticals (SHPH) Is Extremely Volatile TodaySeptember 5, 2024 | msn.comShuttle Pharma Provides Second Quarter 2024 Corporate UpdateSeptember 4, 2024 | globenewswire.comShuttle Pharma Regains Compliance with Nasdaq Minimum Bid Price RequirementAugust 28, 2024 | markets.businessinsider.comShuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharma Receives Notice of Nasdaq Non-Compliance with Listing Rule 5250(c)August 27, 2024 | finanznachrichten.deShuttle Pharma Receives Notice of Nasdaq Non-Compliance with Listing Rule 5250(c)(1)August 26, 2024 | globenewswire.comShuttle Pharma Ready to Enroll Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with GlioblastomaAugust 14, 2024 | globenewswire.comShuttle Pharma's Selective HDAC Inhibitor Exhibits ATM Activation and Modulation of ER Expression Resulting in Substantial Growth Inhibition of Estrogen Receptor Positive Breast Cancer Cells, as Reported in PLOS ONEJuly 19, 2024 | globenewswire.comShuttle Pharma Appoints Timothy Lorber as Chief Financial OfficerJune 18, 2024 | globenewswire.comShuttle Pharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024May 22, 2024 | globenewswire.comShuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharma Provides First Quarter 2024 Corporate UpdateMay 14, 2024 | finanznachrichten.deShuttle Pharma Provides First Quarter 2024 Corporate UpdateMay 14, 2024 | globenewswire.comSHPH Stock Earnings: Shuttle Pharmaceuticals Reported Results for Q1 2024May 13, 2024 | investorplace.comShuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024April 23, 2024 | globenewswire.comShuttle Pharmaceuticals to Present at the Emerging Growth Conference on April 4, 2024April 3, 2024 | globenewswire.comShuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharma Provides Fourth Quarter 2023 Corporate UpdateMarch 22, 2024 | finanznachrichten.deShuttle Pharma Provides Fourth Quarter 2023 Corporate UpdateMarch 22, 2024 | finance.yahoo.comSHPH Stock Earnings: Shuttle Pharmaceuticals Reported Results for Q4 2023March 22, 2024 | msn.comShuttle Pharmaceuticals to Present at the Emerging Growth Conference on March 6, 2024March 5, 2024 | globenewswire.comShuttle Pharma Announces Its Intent to Pursue a Rights OfferingFebruary 13, 2024 | finance.yahoo.comShuttle Pharmaceuticals Acquires Promising Prostate Cancer TechnologyFebruary 6, 2024 | msn.comShuttle Pharmaceuticals Bolsters Investor Relations with New PartnershipFebruary 6, 2024 | msn.comShuttle Pharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024January 23, 2024 | finance.yahoo.comShuttle Pharmaceuticals Receives FDA Approval to Proceed with Phase II Clinical Trial of Ropidoxuridine for Treatment of Patients with GlioblastomaJanuary 8, 2024 | finance.yahoo.comShuttle Pharmaceuticals Submits IND Application to the U.S. FDA for Ropidoxuridine Phase II Clinical Trial for Patients with GlioblastomaDecember 11, 2023 | finance.yahoo.comShuttle Pharmaceuticals to Present at the Emerging Growth Conference on December 7, 2023November 30, 2023 | finance.yahoo.comShuttle Pharmaceuticals reports Q3 resultsNovember 14, 2023 | msn.comShuttle Pharmaceuticals Provides Third Quarter 2023 Corporate UpdateNovember 14, 2023 | finance.yahoo.com Get Shuttle Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SHPH and its competitors with MarketBeat's FREE daily newsletter. Email Address BITCOIN (Ad)Did you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this... Watch this short video SHPH Media Mentions By Week SHPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SHPH News Sentiment▼0.820.68▲Average Medical News Sentiment SHPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SHPH Articles This Week▼40▲SHPH Articles Average Week Get Shuttle Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SHPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TSBX News TLPH News MYNZ News KPRX News VIRX News BCDA News INDP News AYTU News CYCN News RDHL News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SHPH) was last updated on 12/26/2024 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk could help pay for your retirementElon Musk is the richest man in the world... And he's pouring trillions into a unique investment.Brownstone Research | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shuttle Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shuttle Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
